Cyclophosphamide monohydrate is widely used in the treatment of various types of cancer, including lymphoma, leukemia, and solid tumors. It functions as an alkylating agent, interfering with the DNA replication process in cancer cells, thereby inhibiting their growth and proliferation. Additionally, it is employed in high-dose chemotherapy regimens, often in combination with other chemotherapeutic agents, to enhance its efficacy. Beyond oncology, it is utilized in the management of autoimmune diseases such as lupus and rheumatoid arthritis, where it helps suppress the immune system to reduce inflammation and disease progression. In transplant medicine, it is used to prevent organ rejection by modulating immune responses. Its application in these diverse fields underscores its importance in both cancer therapy and immunomodulation.